Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Data presented on a new chimeric antigen receptor targeting cancer

Dec. 30, 2014

FDA approves supplemental BLA for Gazyva

Dec. 30, 2014

Kite Pharma submits IND application for phase I/II trial of KTE-C19

Dec. 29, 2014

First U.S. approval granted for nivolumab injection for metastatic melanoma

Dec. 23, 2014

NETRIS Pharma creates first humanized monoclonal antibody against netrin-1

Dec. 23, 2014

Inovio Pharmaceuticals begins DNA immunotherapy trial for breast, lung and pancreatic cancer

Dec. 23, 2014

Kyowa Hakko Kirin receives additional indication approval for Poteligeo in Japan

Dec. 22, 2014

Preliminary phase I/IIa data for an anticancer vaccine against multiple myeloma

Dec. 18, 2014

Preclinical data for RG-7888 support phase I investigation

Dec. 18, 2014

Prima BioMed initiates pilot trial of CVac in pancreatic cancer

Dec. 18, 2014

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...